Niamh Pellegrini
Direktor/Vorstandsmitglied bei ACUTUS MEDICAL, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Niamh Pellegrini
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACUTUS MEDICAL, INC. | Direktor/Vorstandsmitglied | 10.08.2021 | - |
Independent Dir/Board Member | 10.08.2021 | - |
Karriereverlauf von Niamh Pellegrini
Ehemalige bekannte Positionen von Niamh Pellegrini
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEVRO CORP. | Corporate Officer/Principal | 25.06.2019 | 09.06.2023 |
Abbott Vascular, Inc.
Abbott Vascular, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Vascular, Inc. is a company that manufactures cardiac and vascular care systems. The company is based in Abbott Park, IL. | Corporate Officer/Principal | 01.09.2018 | 01.06.2019 |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Direktor/Vorstandsmitglied | 12.04.2016 | 01.06.2018 |
Vorstandsvorsitzender | 12.04.2016 | 01.06.2018 | |
Präsident | 12.04.2016 | 01.06.2018 | |
THORATEC CORPORATION | Corporate Officer/Principal | 13.10.2014 | 08.10.2015 |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Private Equity Investor | 04.08.2009 | 30.03.2010 |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Direktor/Vorstandsmitglied | 12.07.2010 | - |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 10.03.2010 | - |
Lifescan, Inc.
Lifescan, Inc. Medical/Nursing ServicesHealth Services Lifescan, Inc. engages in the development, manufacture, and market of blood glucose monitoring products. Its portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The company was founded by Gary H. Stroy in 1981 and is headquartered in Wayne, PA. | Corporate Officer/Principal | - | - |
░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Niamh Pellegrini
Santa Clara University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 12 |
Operativ
Corporate Officer/Principal | 5 |
Director/Board Member | 4 |
Private Equity Investor | 1 |
Sektoral
Health Technology | 8 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
JOHNSON & JOHNSON | Health Technology |
NEVRO CORP. | Health Technology |
ACUTUS MEDICAL, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
Lifescan, Inc.
Lifescan, Inc. Medical/Nursing ServicesHealth Services Lifescan, Inc. engages in the development, manufacture, and market of blood glucose monitoring products. Its portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. The company was founded by Gary H. Stroy in 1981 and is headquartered in Wayne, PA. | Health Services |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Health Technology |
Thoratec Corp.
Thoratec Corp. Medical SpecialtiesHealth Technology Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device and Thoratec Implantable Ventricular Assist. It also manufactures and markets the CentriMag Acute Circulatory System, HeartMate II, PVAD, IVAD and for pediatric patients PediMag/PediVAS Acute Circulatory System. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through the Cardiovascular group segment, which develops, manufactures mechanical circulatory products to support the cardiovascular systems of humans and to provide product-related services. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA. | Health Technology |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Technology |
Abbott Vascular, Inc.
Abbott Vascular, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Abbott Vascular, Inc. is a company that manufactures cardiac and vascular care systems. The company is based in Abbott Park, IL. | Health Technology |
- Börse
- Insiders
- Niamh Pellegrini
- Erfahrung